Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs.
We describe a novel strategy to site-specifically mutagenize the genome of an RNA virus by exploiting homologous RNA recombination between synthetic defective interfering (DI) RNA and the viral RNA. Marker mutations introduced in the DI RNA were replaced by the wild-type residues during replication. More importantly, however, these genetic markers were introduced into the viral genome: even in the absence of positive selection MHV recombinants could be isolated. This finding provides new prospects for the study of coronavirus replication using recombinant DNA techniques. As a first application, we describe the rescue of the temperature sensitive mutant MHV Albany-4 using DI-directed mutagenesis. Possibilities and limitations of this strategy are discussed.
van der Most
R
R
Department of Virology, Faculty of Medicine, Leiden University, The Netherlands.
Heijnen
L
L
Spaan
W
W
de Groot
R
R
D001483:Base Sequence; D003673:Defective Viruses / Q000235:genetics*; D005819:Genetic Markers; D016679:Genome, Viral; D008969:Molecular Sequence Data; D006517:Murine hepatitis virus / Q000235:genetics* / Q000502:physiology; D016297:Mutagenesis, Site-Directed; D012367:RNA, Viral / Q000235:genetics*; D011995:Recombination, Genetic; D014779:Virus Replication
D005819:Genetic Markers; D012367:RNA, Viral